Cargando…

Ferroportin in the progression and prognosis of hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is the fifth most common malignant tumor in men and the seventh in women and understanding the molecular mechanisms of HCC and establishing more effective therapies are critical and urgent issues. Our objective was to study the expression of ferroportin in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Qin, Zhou, Jun, Zhong, Dewu, Wang, Qunwei, Huang, Jiangsheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878504/ https://www.ncbi.nlm.nih.gov/pubmed/24360312 http://dx.doi.org/10.1186/2047-783X-18-59

Ejemplares similares

Retraction Note: Ferroportin in the progression and prognosis of hepatocellular carcinoma
por: Wang, Qin, et al.
Publicado: (2015)

Human macrophage ferroportin biology and the basis for the ferroportin disease
por: Sabelli, Manuela, et al.
Publicado: (2017)

Pediatric Ferroportin Disease
por: Galicia-Poblet, Gonzalo, et al.
Publicado: (2016)

Decreased expression of ferroportin in prostate cancer
por: Xue, Dong, et al.
Publicado: (2021)

Mechanism of Ca(2+) transport by ferroportin
por: Shen, Jiemin, et al.
Publicado: (2023)

A disease-causing mutation K240E disrupts ferroportin trafficking by SUMO (ferroportin SUMOylation)
por: Bayele, Henry K., et al.
Publicado: (2021)

Ferroportin depletes iron needed for cell cycle progression in head and neck squamous cell carcinoma
por: Belvin, Benjamin Ross, et al.
Publicado: (2023)

Ferroportin and Erythroid Cells: An Update
por: Cianetti, Luciano, et al.
Publicado: (2010)

Ferroportin and hepcidin: a new hope in diagnosis, prognosis, and therapy for breast cancer
por: Pogribny, Igor P
Publicado: (2010)

Structural basis of ion transport and inhibition in ferroportin
por: Pan, Yaping, et al.
Publicado: (2020)

NSUN5 promotes progression and predicts poor prognosis in hepatocellular carcinoma
por: Zhang, Xiao-Wen, et al.
Publicado: (2022)

Structural basis of ferroportin inhibition by minihepcidin PR73
por: Wilbon, Azaan Saalim, et al.
Publicado: (2023)

Ferroportin disease: pathogenesis, diagnosis and treatment
por: Pietrangelo, Antonello
Publicado: (2017)

Pharmacological Targeting of the Hepcidin/Ferroportin Axis
por: Sebastiani, Giada, et al.
Publicado: (2016)

Isolation and thermal stabilization of mouse ferroportin
por: Deshpande, Chandrika N., et al.
Publicado: (2020)

Hepcidin induces HIV-1 transcription inhibited by ferroportin
por: Xu, Min, et al.
Publicado: (2010)

Therapeutic Advances in Regulating the Hepcidin/Ferroportin Axis
por: Hawula, Zachary J., et al.
Publicado: (2019)

The Role of Copper in the Regulation of Ferroportin Expression in Macrophages
por: Jończy, Aneta, et al.
Publicado: (2021)

Bioinformatics analysis to identify the key genes affecting the progression and prognosis of hepatocellular carcinoma
por: Zhang, Yingai, et al.
Publicado: (2019)

The correlation of EZH2 expression with the progression and prognosis of hepatocellular carcinoma
por: Wu, Shi-yi, et al.
Publicado: (2022)

Numb downregulation suppresses cell growth and is associated with a poor prognosis of human hepatocellular carcinoma
por: XIE, CHENGZHI, et al.
Publicado: (2015)

Allele Loss and Down-Regulation of Heparanase Gene Are Associated with the Progression and Poor Prognosis of Hepatocellular Carcinoma
por: Huang, Guo-Liang, et al.
Publicado: (2012)

Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer’s disease
por: Bao, Wen-Dai, et al.
Publicado: (2021)

CBX6 overexpression contributes to tumor progression and is predictive of a poor prognosis in hepatocellular carcinoma
por: Zheng, Hao, et al.
Publicado: (2017)

Decreased Cezanne expression is associated with the progression and poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

High Expression of FLOT1 Is Associated with Progression and Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Shi-Hong, et al.
Publicado: (2013)

Duodenal Ferroportin Is Up-Regulated in Patients with Chronic Hepatitis C
por: Ma, Lanqing, et al.
Publicado: (2014)

Targeting the Hepcidin-Ferroportin Axis in the Diagnosis and Treatment of Anemias
por: Nemeth, Elizabeta
Publicado: (2010)

Iron Availability in Tissue Microenvironment: The Key Role of Ferroportin
por: Gammella, Elena, et al.
Publicado: (2021)

UBA6 and NDFIP1 regulate the degradation of ferroportin
por: Traeger, Lisa, et al.
Publicado: (2021)

Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis
por: Nemeth, Elizabeta, et al.
Publicado: (2021)

Structures of ferroportin in complex with its specific inhibitor vamifeport
por: Lehmann, Elena Farah, et al.
Publicado: (2023)

Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma
por: Fu, Shun-Jun, et al.
Publicado: (2018)

Upregulation of FEN1 Is Associated with the Tumor Progression and Prognosis of Hepatocellular Carcinoma
por: Zhang, Yingying, et al.
Publicado: (2020)

PSCA and Oct-4 Expression in the Benign and Malignant Lesions of Gallbladder: Implication for Carcinogenesis, Progression, and Prognosis of Gallbladder Adenocarcinoma
por: Zou, Qiong, et al.
Publicado: (2013)

Embryonic Morphogen Nodal Is Associated with Progression and Poor Prognosis of Hepatocellular Carcinoma
por: Chen, Jing, et al.
Publicado: (2014)

Lost expression of ADAMTS5 protein associates with progression and poor prognosis of hepatocellular carcinoma
por: Li, Chongyi, et al.
Publicado: (2015)

High expression of TOP2A in hepatocellular carcinoma is associated with disease progression and poor prognosis
por: Cai, Hongyu, et al.
Publicado: (2020)

The role of DEK protein in hepatocellular carcinoma for progression and prognosis
por: Lin, Li-juan, et al.
Publicado: (2013)

Upregulation of microRNA-25 associates with prognosis in hepatocellular carcinoma
por: Su, Zhong-xue, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_47jejlj9pke1f3pqvb8su4r130